Valstar - For therapy of BCG-refractory urinary bladder carcinoma

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1048 / 1048
页数:1
相关论文
共 50 条
  • [1] Endovesical treatment with gemcitabine in patients with BCG-refractory superficial bladder carcinoma
    Gunelli, R.
    Frassineti, G. L.
    Giovannini, N.
    Zoli, W.
    Fiori, M.
    Amadori, D.
    Fabbri, P.
    Bercovich, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI78 - XI78
  • [2] ENDOVESICAL TREATMENT WITH GEMCITABINE IN PATIENTS WITH BCG-REFRACTORY SUPERFICIAL BLADDER CARCINOMA
    Gunelli, Roberta
    Frassineti, Giovanni Luca
    Giovannini, Noemi
    Zoli, Wainer
    Fiori, Massimo
    Saltutti, Carlo
    Amadori, Dino
    Bercovich, Eduard
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 95 - 96
  • [3] MANAGEMENT OF BCG-REFRACTORY SUPERFICIAL BLADDER CANCER
    Soyupak, Bulent
    [J]. TURKISH JOURNAL OF UROLOGY, 2005, 31 (04): : 465 - 468
  • [4] Gemcitabine as an endovesical treatment in patients with BCG-refractory superficial bladder carcinoma.
    Gunelli, R
    Frassineti, GL
    Giovannini, N
    Zoli, W
    Fiori, M
    Amadori, D
    Fabbri, R
    Bercovich, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 429S - 429S
  • [5] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, SM
    Herr, HW
    Sogani, P
    Depalma, D
    Bajorin, D
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
  • [6] Sunitinib in BCG-refractory non-muscle-invasive transitional cell carcinoma of the bladder
    Garcia, J. A.
    Stephenson, A. J.
    Ireland, J.
    Finke, J.
    Elson, P.
    Schaaf, L.
    Gong, M. C.
    Campbell, S.
    Dreicer, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Ben-Porat, L
    Donat, SM
    Herr, HW
    Bochner, BH
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
  • [8] Is Intravesical Gene Therapy for Patients with BCG-refractory NMIBC?
    Bohle, A.
    [J]. UROLOGE, 2021, 60 (03): : 372 - 373
  • [9] Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: An investigational approach
    Luciani, LG
    Neulander, E
    Murphy, WM
    Wajsman, Z
    [J]. UROLOGY, 2001, 58 (03) : 376 - 379
  • [10] Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study
    Gunelli, R.
    Bercovich, E.
    Nanni, O.
    Ballardini, M.
    Frassineti, G. L.
    Giovannini, N.
    Fiori, M.
    Pasquini, E.
    Ulivi, P.
    Pappagallo, G. L.
    Silvestrini, R.
    Zoli, W.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (11) : 1499 - 1504